<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-LWHU3XG4</identifier><date>2024</date><creator>Mesti, Tanja</creator><creator>Tomič, Blaž</creator><relation>documents/doc/L/URN_NBN_SI_doc-LWHU3XG4_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LWHU3XG4_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 211-214</format><identifier identifier_type="COBISSID_HOST">189000451</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LWHU3XG4</identifier><language>slv</language><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo SZD</publisher><source>Dnevi internistične onkologije 2024</source><rights>InC</rights><subject language_type_id="slv">astrocitom</subject><subject language_type_id="slv">internistična onkologija</subject><subject language_type_id="slv">kemoterapija</subject><title>Zdravljenje IDH1 astrocitoma</title><title>prikaz primera</title></Record>